Journal of Clinical Endocrinology & Metabolism, Vol 77, 1142-1147, Copyright © 1993 by Endocrine Society

ARTICLES

Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus

A Hilding, K Brismar, M Thoren and K Hall
Department of Endocrinology, Karolinska Institute, Stockholm, Sweden.

Glucagon (1-1.5 mg) was administrated iv as a bolus dose to healthy individuals (n = 7), patients with GH deficiency (n = 14), and patients with insulin-dependent diabetes mellitus (IDDM; n = 6). Thereafter, blood samples for determination of serum glucose, insulin, insulin-like growth factor-binding protein-1 (IGFBP-1), GH, and insulin-like growth factor-I (IGF-I) concentrations were collected for 180 min. IGFBP-1 concentrations increased significantly in response to glucagon, with maximal values observed at 90 min [in healthy subjects from 36 +/- 6 to 58 +/- 10 micrograms/L (P < 0.05), in GH-deficient patients from 36 +/- 4 to 54 +/- 6 micrograms/L (P < 0.001), and in IDDM patients from 115 +/- 18 to 167 +/- 27 micrograms/L (P < 0.05)]. The IGFBP-1 elevation was delayed in relation to the glucagon-induced increase in glucose and insulin concentrations. When the groups were combined, the individual IGFBP-1 peak value observed at 90 min was inversely correlated to the individual peak value of insulin observed at 15-30 min (r = -0.743; P < 0.001). In GH-deficient patients, serum GH concentrations remained undetectable (< 0.2 micrograms/L), and IGF-I concentrations were unchanged after the glucagon injection. In healthy subjects and IDDM patients, mean GH levels did not change significantly, whereas mean IGF- I concentrations decreased slightly at 30 min. In conclusion, glucagon increased serum IGFBP-1 concentrations in spite of increases in glucose and insulin. These results suggest that glucagon is a stimulator of IGFBP-1.

This article has been cited by other articles:

				S B Catrina, R Rotarus, I R Botusan, M Coculescu, and K Brismar Desmopressin increases IGF-binding protein-1 in humans. Eur. J. Endocrinol., April 1, 2008; 158(4): 479 - 482. [Abstract] [Full Text] [PDF]

				K. R. Short, J. Nygren, M. L. Bigelow, and K. S. Nair Effect of Short-Term Prednisone Use on Blood Flow, Muscle Protein Metabolism, and Function J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6198 - 6207. [Abstract] [Full Text] [PDF]

				J. Nygren, C. Carlsson-Skwirut, K. Brismar, A. Thorell, O. Ljungqvist, and P. Bang Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E736 - E741. [Abstract] [Full Text] [PDF]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				D.-S. Suh and M. M. Rechler Hepatocyte Nuclear Factor 1 and the Glucocorticoid Receptor Synergistically Activate Transcription of the Rat Insulin-like Growth Factor Binding Protein-1 Gene Mol. Endocrinol., November 1, 1997; 11(12): 1822 - 1831. [Abstract] [Full Text]

				E. Fernqvist-Forbes, A. Hilding, K. Ekberg, and K. Brismar Influence of Circulating Epinephrine and Norepinephrine on Insulin-Like Growth Factor Binding Protein-1 in Humans J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2677 - 2680. [Abstract] [Full Text] [PDF]